Resect face/scalp tum 2 cm/>
CPT code 21016 covers the surgical removal of a tumor or lesion from the face or scalp that measures 2 centimeters or larger. This is a more extensive procedure than simple skin excision, involving deeper tissue and more complex reconstruction.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Measure and document the tumor size precisely in the operative note, specifying measurement method (clinical vs pathologic), as size determines code selection between 21011, 21012, 21013, 21014, and 21016
Impact: Proper size documentation justifies the $983.66 payment versus $562-$783 for smaller lesion codes; underdocumentation results in downcoding losses of $200-$400
Document depth of excision beyond simple dermis to justify 21016 versus integumentary system codes (11640-11646); note involvement of subcutaneous tissue, fascia, muscle, or bone
Impact: Differentiates surgical excision ($983.66) from skin excision codes ($200-$500); inadequate depth documentation leads to denials averaging $500+ in lost revenue
Do not separately bill for simple or intermediate closure as it is included in 21016; only bill complex closure (13100-13153) or reconstruction (14000-14302) if performed and documented
Impact: Avoid bundling denials while capturing legitimate additional procedures; complex closure can add $300-$800 when appropriately documented and medically necessary
When performed in facility setting, verify the facility is billing the technical component; physician should bill with place of service code 22 (outpatient hospital) or 24 (ASC)
Impact: Both facility and non-facility rates are $983.66 for 21016, but incorrect POS coding can trigger audit flags and delay payment
Link appropriate diagnosis codes specifying benign versus malignant nature and exact anatomic location (C43.xx, C44.xx, D23.xx series) to support medical necessity
Impact: Malignant diagnoses typically have stronger medical necessity; vague or unspecified diagnoses increase denial risk by 30-40%
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.